Sat.May 29, 2021 - Fri.Jun 04, 2021

An AstraZeneca, Merck drug slows the return of genetic breast cancer. Will testing speed up?

Bio Pharma Dive

Study results disclosed ahead of ASCO could make Lynparza a standard "adjuvant" treatment for people with an inherited form of breast cancer — as long as they know they have it

Personal responsibility in the obesity epidemic

World of DTC Marketing

SUMMARY: The U.S. is one of the wealthiest countries in the world and accordingly has high obesity rates; one-third of the population has obesity plus another third is overweight. The cost of doing nothing is not an option.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

In the News: May 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Approval of the Month: Non-Opioid for Post-Surgical Pain Gets FDA Nod.

Ketamine as a Depression Treatment Saved Me

NY Times

I tried everything to treat my depression. Ketamine is the one thing that worked. Mental Health and Disorders Depression (Mental) Drugs (Pharmaceuticals

Drugs 94

MorphoSys to buy Constellation in $1.7B deal, aided by unusual funding

Bio Pharma Dive

Royalty Pharma will effectively fund MorphoSys' acquisition of the cancer biotech through a separate agreement to buy MorphoSys' shares of royalties on several marketed and experimental medicines

The Future of Health Care

World of DTC Marketing

IN SHORT : Out-of-control health care spending exact an enormous and growing toll on Americans. The scale of the broken US health care system reveals itself in tragic ways. Fraud accounts for about $300 billion of annual US health care spending.

70-year-old coffee-killing fungus brought back to life to fight the disease

Scienmag

Credit: CABI Researchers have re-animated specimens of a fungus that causes coffee wilt to discover how the disease evolved and how its spread can be prevented.

More Trending

Bayer buys a biotech and its offshoot in bet on radiopharmaceuticals

Bio Pharma Dive

The German drugmaker will add an experimental prostate cancer medicine to its pipeline through the deal, which reflects growing industry interest in the field

Disruption my ass! Tech companies want healthcare dollars

World of DTC Marketing

SUMMARY: Amazon has set its sights on healthcare as it smells another profit opportunity.

Novo Nordisk crowns cell therapy pipeline with $598m Heartseed deal

Pharma Phorum

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed.

Calliditas is Getting to the Heart of Berger’s Disease

BioSpace

Calliditas is developing Nefecon, a down regulator of IgA1 and proprietary, novel oral formulation of budesonide – a potent and established immunosuppressant – for the treatment of IgAN

Biotech venture capital still booming as venBio raises another $550M

Bio Pharma Dive

VenBio has previously invested in a range of treatment areas and technologies, including cell and gene editing companies like Precision Bio and Artiva

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post , says “the worst thing for people with Alzheimer’s would be to put out a product that doesn’t work.”

Drugs 157

New marine scale worm species first to provide evidence of male dwarfism

Scienmag

Credit: Toba Aquarium In the Kumano Sea, off the southeast coast of Japan, an evolutionary mystery lay in wait. Researchers collected samples from the muddy sea floor, including hermit crabs, mollusks and discarded shells.

BioAro Inc. and CardiAI Launches Rapid PCR Testing Services in the Northwest Territories at Gahcho Kué Mine:

BioTech 365

BioAro Inc. and CardiAI Launches Rapid PCR Testing Services in the Northwest Territories at Gahcho Kué Mine: BioAro Inc.

52

Novartis prostate cancer drug extends survival in key test of radiopharmaceutical therapy

Bio Pharma Dive

Results from the Phase 3 trial, which Novartis plans to use to ask for approval, help validate the pharma's bet on the therapy's original developer, Endocyte

Trials 171

Communicating with HCPs via email

World of DTC Marketing

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. That should, however, not discourage the use of email to HCPs.

Robots with T-ray technology to spot and remove cancer tumors in £8 million project

Scienmag

Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL

BioTech 365

Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination … Continue reading → Business Wire

52

Alexion, AstraZeneca executives switch roles amid $39B buyout

Bio Pharma Dive

Marc Dunoyer, the U.K. drugmaker's longtime finance chief, will move over to a strategy role and run Alexion as a rare disease unit within AstraZeneca

168
168

4 Notable Life Sciences Trends from the Tech Trends Report

Pharma R&D Today

The Future Today Institute has released its 2021 Tech Trends Report (14 th Annual Edition), a comprehensive report on strategic trends that it anticipates will affect business, government, education, media and society in the coming year.

Colorectal Cancer: UVA Health Expert Helps Develop New National Screening Guidelines

Scienmag

Screenings Recommended to Begin at Age 45 Credit: UVA Health Most Americans should get screened for colorectal cancer beginning at age 45 instead of age 50, according to new recommendations from the U.S. Preventive Services Task Force, which includes UVA Health’s Li Li, MD, PhD, MPH.

ADC Therapeutics Presents Updated Clinical Data at 2021 ASCO Annual Meeting

BioTech 365

ADC Therapeutics Presents Updated Clinical Data at 2021 ASCO Annual Meeting ADC Therapeutics Presents Updated Clinical Data at 2021 ASCO Annual Meeting ZYNLONTA™ LOTIS-2 updated data includes median duration of response of 13.4

52

Amgen pays $400M for an eczema drug, putting faith in an old partner

Bio Pharma Dive

A deal with Kyowa Kirin gives Amgen rights to an experimental treatment aimed at an autoimmune target that has drawn interest from multiple drugmakers

Drugs 168

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Pharma Mirror

Avantor, Inc.

nTIDE May 2021 Jobs Report: Slow improvement as economy strives for recovery

Scienmag

First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research

BioTech 365

First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing … Continue reading → Business Wire

Bristol Myers sued over delayed approval of cancer cell therapy

Bio Pharma Dive

A bank representing former Celgene shareholders claims Bristol Myers did not work diligently to secure FDA clearance of Breyanzi, one of three drugs covered by a $6.4 billion agreement between the two companies

Drugs 153

ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain

Pharma Mirror

Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19.

Corals tell Arabian Sea story of global warming

Scienmag

Credit: Tsuyoshi Watanabe Coral insights into 1,000 years of seasonal changes in the Arabian Sea warn of significant impacts caused by global warming.

52

 Seres Therapeutics Presents Research from its Early-Stage Microbiome Therapeutic Oncology Programs at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

BioTech 365

Orchard abandons promising gene therapy for rare immune disorder

Bio Pharma Dive

The U.K. biotech deprioritized the therapy last year, despite positive results in clinical testing that were recently published in a top medical journal

Syntegon’s Slide Gate Technology Improves Capsule Filling Performance

Syntegon Technology Pharma Blog

Solid Dosage Capsule Filling Oral Solid Dosage ShapingTheFuture

52

ADHD medications associated with reduced risk of suicidality in certain children

Scienmag

Drugs 52

With Hundreds of Bio Industry Jobs Open and Company Expansions Underway, Companies Are Investing in Industry-Intensive Training and Professional Development

BioTech 365

Sanofi rare disease drug hits another setback

Bio Pharma Dive

The French pharma halted a late-stage trial of venglustat, one of its priority drug candidates, in a type of kidney disease, months after stopping testing in Parkinson's

Trials 153

Decentralized Clinical Trials: A patient-centric way forward

Clairnes

The post Decentralized Clinical Trials: A patient-centric way forward appeared first on Clinical Trial Recruitment & Management Services.